How do analysts rate FORWARD PHARMA A/S-ADR (FWP)?
The consensus rating for FORWARD PHARMA A/S-ADR (FWP) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
FORWARD PHARMA A/S-ADR (FWP) Forecast, Price Target & Analyst Ratings
NASDAQ:FWP • US34986J2042
Current stock price
1.95 USD
+0.14 (+7.73%)
At close:
1.5 USD
-0.45 (-23.08%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FORWARD PHARMA A/S-ADR (FWP).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $1.95 to mean target of $0.00, Based on 8 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.00%
FWP was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about FWP.
In the previous month the buy percentage consensus was at a similar level.
FWP was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.25B | -100.00% | N/A | |||||
| EBITDA YoY % growth | -49.6M | -55.3M -11.49% | 1.188B 2,247.56% | N/A -101.04% | N/A 56.91% | N/A 35.85% | N/A -13.94% | |
| EBIT YoY % growth | -49.6M | -55.4M -11.69% | 1.187B 2,243.32% | -24.412M -101.04% | N/A 56.91% | N/A 35.85% | N/A -13.94% | |
| Operating Margin | N/A | N/A | 94.99% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -7.80 | -8.12 -4.13% | N/A 19.50% | -4.99 23.66% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A